FOLD
Amicus Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$14.49
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 16.29x
- Price / sales
- 7.05x
- Price / cash flow
- 134.81x
Enterprise value
- Enterprise value
- $4.7B
- EV / sales
- 7.34x
- EV / EBITDA
- 86.56x
- EV / EBIT
- 142.06x
- Market cap
- $4.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025